Novo Nordisk invests $100m in China expansion ahead of 2015 target
This article was originally published in Scrip
Executive Summary
Novo Nordisk has invested $100 million to expand its R&D centre in Beijing, increasing the number of R&D employees from 130 to 200 with space available for future growth.